Sustain Iii Calf

Sustain Iii Calf Manufacturers

• Vet One
  

  ×

  Sustain Iii Calf | Vet One

  

  ---

  Dosage and Administration: Sustain III Calf Boluses (Sulfamethazine Sustained Release Boluses) are designed to be administered orally to ruminating replacement calves. (See CAUTION Statement).  Sustain III Calf Boluses should be given according to the following dosage schedule. 
  

  No. of Boluses                            2                   3                  4                  5                  6

  Animal Body Weight                100 lbs            150 lbs         200 lbs          250 lbs          300 lbs

  This bolus may be divided for better approximation of the correct dose; however, care should be taken not to crush the bolus.  Care should also be taken to ensure the entire dose has been swallowed by the animal.  Observe animals following the administration to ensure boluses are not regurgitated.  Lubricate bolus before dosing animals. 
  

  Sustain III Calf Boluses are designed to provide a therapeutic sulfamethazine level in approximately 6 hours, and persist in providing this level for 72 hours (3 days).  After 72 hours, all animals should be re-examined for persistence of observable disease signs.  If signs are present, consult a veterinarian.  It is strongly recommended that a second dose be given to provide an additional 72 hours of therapy, particularly in those more severe cases.  The above schedule should be used at each 72-hour interval. 
  

  
  

  Close
  No Recall

  More Info
• Bimeda, Inc. Division Of Cross Vetpharm Group Ltd
  

  ×

  Sustain Iii Calf | American Health Packaging

  

  ---

  2.1 Recommended Dosing Schedule

  Pantoprazole is supplied as delayed-release tablets. The recommended dosages are outlined in Table 1.

  Table 1: Recommended Dosing Schedule for Pantoprazole Indication Dose Frequency *     For adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of Pantoprazole may be considered.
  **   Dosage regimens should be adjusted to individual patient needs and should continue for as long as clinically indicated. Doses up to 240 mg daily have been administered.
  *** Controlled studies did not extend beyond 12 months
  

   Short-Term Treatment of Erosive Esophagitis Associated With GERD

     Adults

   40 mg

   Once daily for up to 8 weeks*

     Children (5 years and older)

   

   

     ≥ 15 kg to < 40 kg

   20 mg

   Once daily for up to 8 weeks

     ≥ 40 kg

   40 mg

   

   Maintenance of Healing of Erosive Esophagitis

     Adults

   40 mg

   Once daily***

   Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome

     Adults

   40 mg

   Twice daily**

  2.2 Administration Instructions

  Directions for method of administration for each dosage form are presented in Table 2.

  Table 2: Administration Instructions Formulation Route Instructions* * Patients should be cautioned that Pantoprazole Sodium Delayed-Release Tablets should not be split, chewed, or crushed.

  Delayed-Release Tablets

   Oral

   Swallowed whole, with or without food

  Pantoprazole Sodium Delayed-Release Tablets

  Pantoprazole Sodium Delayed-Release Tablets should be swallowed whole, with or without food in the stomach. If patients are unable to swallow a 40 mg tablet, two 20 mg tablets may be taken. Concomitant administration of antacids does not affect the absorption of Pantoprazole Sodium Delayed-Release Tablets.

  Close
  No Recall

  More Info